Cargando…
Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471071/ https://www.ncbi.nlm.nih.gov/pubmed/28545220 http://dx.doi.org/10.18632/oncotarget.18067 |
| _version_ | 1783243883457544192 |
|---|---|
| author | Yang, Yu-Chen SH Chin, Yu-Tang Hsieh, Meng-Ti Lai, Hsuan-Yu Ke, Chien-Chih Crawford, Dana R. Lee, Oscar K. Fu, Earl Mousa, Shaker A. Grasso, Patricia Liu, Leroy F. Chang, Heng-Yu Tang, Heng-Yuan Lin, Hung-Yun Davis, Paul J. |
| author_facet | Yang, Yu-Chen SH Chin, Yu-Tang Hsieh, Meng-Ti Lai, Hsuan-Yu Ke, Chien-Chih Crawford, Dana R. Lee, Oscar K. Fu, Earl Mousa, Shaker A. Grasso, Patricia Liu, Leroy F. Chang, Heng-Yu Tang, Heng-Yuan Lin, Hung-Yun Davis, Paul J. |
| author_sort | Yang, Yu-Chen SH |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5471071 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54710712017-06-27 Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin Yang, Yu-Chen SH Chin, Yu-Tang Hsieh, Meng-Ti Lai, Hsuan-Yu Ke, Chien-Chih Crawford, Dana R. Lee, Oscar K. Fu, Earl Mousa, Shaker A. Grasso, Patricia Liu, Leroy F. Chang, Heng-Yu Tang, Heng-Yuan Lin, Hung-Yun Davis, Paul J. Oncotarget Correction Impact Journals LLC 2017-05-22 /pmc/articles/PMC5471071/ /pubmed/28545220 http://dx.doi.org/10.18632/oncotarget.18067 Text en Copyright: © 2017 Yang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Yang, Yu-Chen SH Chin, Yu-Tang Hsieh, Meng-Ti Lai, Hsuan-Yu Ke, Chien-Chih Crawford, Dana R. Lee, Oscar K. Fu, Earl Mousa, Shaker A. Grasso, Patricia Liu, Leroy F. Chang, Heng-Yu Tang, Heng-Yuan Lin, Hung-Yun Davis, Paul J. Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin |
| title | Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin |
| title_full | Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin |
| title_fullStr | Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin |
| title_full_unstemmed | Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin |
| title_short | Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin |
| title_sort | correction: novel leptin ob3 peptide-induced signaling and progression in thyroid cancers: comparison with leptin |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471071/ https://www.ncbi.nlm.nih.gov/pubmed/28545220 http://dx.doi.org/10.18632/oncotarget.18067 |
| work_keys_str_mv | AT yangyuchensh correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT chinyutang correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT hsiehmengti correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT laihsuanyu correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT kechienchih correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT crawforddanar correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT leeoscark correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT fuearl correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT mousashakera correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT grassopatricia correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT liuleroyf correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT changhengyu correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT tanghengyuan correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT linhungyun correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin AT davispaulj correctionnovelleptinob3peptideinducedsignalingandprogressioninthyroidcancerscomparisonwithleptin |